Pulmonary Fibrosis Pipeline Review, H1 Market ,Growth and Price Analysis and Forecast 2016

Pulmonary Fibrosis Market Size, Share, Analysis and Causes, Symptoms, Treatment, Pipeline Review, H1 2016

Global Markets Direct’s, ‘Pulmonary Fibrosis – Pipeline Review, H1 2016′, provides an overview of the Pulmonary Fibrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pulmonary Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Fibrosis and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Browse Detail Report With TOC @ http://www.radiantinsights.com/research/pulmonary-fibrosis-pipeline-review-h1-2016

Reasons to Buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Table of Content

Table of Contents 2
List of Tables 7

Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports

List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Pulmonary Fibrosis Overview 11
Therapeutics Development 12
Pipeline Products for Pulmonary Fibrosis – Overview 12
Pipeline Products for Pulmonary Fibrosis – Comparative Analysis 13
Pulmonary Fibrosis – Therapeutics under Development by Companies 14
Pulmonary Fibrosis – Therapeutics under Investigation by Universities/Institutes 20
Pulmonary Fibrosis – Pipeline Products Glance 21
Clinical Stage Products 21
Early Stage Products 22
Pulmonary Fibrosis – Products under Development by Companies 23
Pulmonary Fibrosis – Products under Investigation by Universities/Institutes 30
Pulmonary Fibrosis – Companies Involved in Therapeutics Development 31
AdAlta Pty Ltd. 31
Advinus Therapeutics Ltd. 32

Browse Full Report @ http://www.radiantinsights.com/research/pulmonary-fibrosis-pipeline-review-h1-2016

About Us:

Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:

Michelle Thoras
Corporate Sales Specialist, USA

Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: sales@radiantinsights.com